Cargando…
Estrogen-related receptor alpha drives mitochondrial biogenesis and resistance to neoadjuvant chemoradiation in esophageal cancer
Neoadjuvant chemoradiotherapy (nCRT) improves outcomes in resectable esophageal adenocarcinoma (EAC), but acquired resistance precludes long-term efficacy. Here, we delineate these resistance mechanisms. RNA sequencing on matched patient samples obtained pre-and post-neoadjuvant treatment reveal tha...
Autores principales: | Dings, Mark P.G., van der Zalm, Amber P., Bootsma, Sanne, van Maanen, Tatum F.J., Waasdorp, Cynthia, van den Ende, Tom, Liu, Dajia, Bailey, Peter, Koster, Jan, Zwijnenburg, Danny A., Spek, C. Arnold, Klomp, Jan P.G., Oubrie, Arthur, Hooijer, Gerrit K.J., Meijer, Sybren L., van Berge Henegouwen, Mark I., Hulshof, Maarten C., Bergman, Jacques, Oyarce, Cesar, Medema, Jan Paul, van Laarhoven, Hanneke W.M., Bijlsma, Maarten F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729822/ https://www.ncbi.nlm.nih.gov/pubmed/36334593 http://dx.doi.org/10.1016/j.xcrm.2022.100802 |
Ejemplares similares
-
Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma
por: Ebbing, Eva A., et al.
Publicado: (2019) -
Chemoradiation induces epithelial‐to‐mesenchymal transition in esophageal adenocarcinoma
por: Steins, Anne, et al.
Publicado: (2019) -
ADAM10-mediated release of heregulin confers resistance to trastuzumab by activating HER3
por: Ebbing, Eva A., et al.
Publicado: (2016) -
Stromal SPOCK1 supports invasive pancreatic cancer growth
por: Veenstra, Veronique L., et al.
Publicado: (2017) -
Tumor‐immune landscape patterns before and after chemoradiation in resectable esophageal adenocarcinomas
por: Soeratram, Tanya TD, et al.
Publicado: (2021)